Introduction: Review Series – Connected Health

Caulfield, B.M.
August 2013
QJM: An International Journal of Medicine;Aug2013, Vol. 106 Issue 8, p701
Academic Journal
No abstract available.


Related Articles

  • Surrogatendpunkte als Parameter der Nutzenbewertung. Mangiapane, Sandra; Velasco^Garrido, Marcial // GMS Health Technology Assessment;2009, Vol. 5, p1 

    The different actors involved in health system decision-making and regulation have to deal with the question which are valid parameters to assess the health value of health technologies. So called surrogate endpoints represent in the best case preliminary steps in the casual chain leading to the...

  • Methoden zur frühen entwicklungsbegleitenden Bewertung innovativer medizinischer Technologien. Bartelmes, Marc; Neumann, Ulrike; Lühmann, Dagmar; Schönermark, Matthias P.; Hagen, Anja // GMS Health Technology Assessment;2009, Vol. 5, p1 

    Conventional Health Technology Assessment (HTA) is usually conducted at a point in time at which the development of the respective technology may no longer be influenced. By this time developers and/or purchasers may have misinvested resources. Thus the demand for Technology Assessment (TA)...

  • Achieving Dependability in the Configuration, Integration and Testing of Healthcare Technologies. Martin, David; Hartswood, Mark; Slack, Roger; Voss, Alex // Computer Supported Cooperative Work: The Journal of Collaborativ;Nov2006, Vol. 15 Issue 5/6, p467 

    This paper presents two case studies, which highlight the practical work involved in developing and deploying dependable healthcare systems. It shows how dependability is a thoroughgoingly practical, contexted achievement. We show how dependability is an outcome of the reasoning and...

  • Disruptive Innovations and Health Care Reform. Kirch, Darrell G.; Brook, Robert H. // JAMA: Journal of the American Medical Association;2/17/2010, Vol. 303 Issue 7, p620 

    Two letters to the editor are presented in response to the article "Disruption and Innovation in Health Care," by R. H. Brook, published in the 2009 issue, including a comment on the article and the author's reply.

  • Technology in the crosshairs. Berci, G. // Surgical Endoscopy;Nov2003, Vol. 17 Issue 11, p1691 

    Comments on the addition of a new technology section in the periodical "Surgical Endoscopy,". Objectives of the new section; Recognition of the increasing role played by new technology in surgical endoscopy.

  • Reporting guidelines for modelling studies. Bennett, Carol; Manuel, Douglas G. // BMC Medical Research Methodology;2012, Vol. 12 Issue 1, p168 

    Background: Modelling studies are used widely to help inform decisions about health care and policy and their use is increasing. However, in order for modelling to gain strength as a tool for health policy, it is critical that key model factors are transparent so that users of models can have a...

  • Incidental Findings and Ancillary-Care Obligations. Richardson, Henry S. // Journal of Law, Medicine & Ethics;Summer2008, Vol. 36 Issue 2, p256 

    Recent work on incidental fndings, concentrating on the difcult problems posed by the ambiguous results often generated by high-tech medicine, has proceeded largely independently from recent work on medical researchers' ancillary-care obligations, the obligations that researchers have to deal...

  • Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme. Green, William; Hutton, John // European Journal of Health Economics;Jun2014, Vol. 15 Issue 5, p449 

    The author discusses the Health technology assessments in England along with the analysis of National Institute for Health and Care Excellence (NICE), Great Britain. Topics discussed include the guidance provided by NICE on clinical practice and health technologies in England, appraisal...

  • A method for addressing research gaps in HTA, developed whilst evaluating robotic-assisted surgery: a proposal. Ballini, Luciana; Minozzi, Silvia; Negro, Antonella; Pirini, Giampiero; Grilli, Roberto // Health Research Policy & Systems;2010, Vol. 8, p27 

    Background: When evaluating health technologies with insufficient scientific evidence, only innovative potentials can be assessed. A Regional policy initiative linking the governance of health innovations to the development of clinical research has been launched by the Region of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics